222 related articles for article (PubMed ID: 34888236)
21. Detection of cryptic CCND1 rearrangements in mantle cell lymphoma by next generation sequencing.
Polonis K; Schultz MJ; Olteanu H; Smadbeck JB; Johnson SH; Vasmatzis G; Xu X; Greipp PT; Ketterling RP; Hoppman NL; Baughn LB; Peterson JF
Ann Diagn Pathol; 2020 Jun; 46():151533. PubMed ID: 32408254
[TBL] [Abstract][Full Text] [Related]
22. [Clinical and biological features and prognosis of patients with leukemic non-nodal mantle cell lymphoma].
Chen JW; Wang Y; Yan YT; Xiong WJ; Wang TY; Liu W; Zou DH; Qiu LG; Yi SH
Zhonghua Yi Xue Za Zhi; 2023 Jun; 103(23):1746-1752. PubMed ID: 37305933
[No Abstract] [Full Text] [Related]
23. Molecular Pathogenesis of Mantle Cell Lymphoma.
Navarro A; Beà S; Jares P; Campo E
Hematol Oncol Clin North Am; 2020 Oct; 34(5):795-807. PubMed ID: 32861278
[TBL] [Abstract][Full Text] [Related]
24. Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas.
Wlodarska I; Dierickx D; Vanhentenrijk V; Van Roosbroeck K; Pospísilová H; Minnei F; Verhoef G; Thomas J; Vandenberghe P; De Wolf-Peeters C
Blood; 2008 Jun; 111(12):5683-90. PubMed ID: 18391076
[TBL] [Abstract][Full Text] [Related]
25. Leukemic Variant of Mantle Cell Lymphoma: Clinical Presentation and Management.
Isaac KM; Portell CA; Williams ME
Curr Oncol Rep; 2021 Jul; 23(9):102. PubMed ID: 34269910
[TBL] [Abstract][Full Text] [Related]
26. Multiple recurrent chromosomal breakpoints in mantle cell lymphoma revealed by a combination of molecular cytogenetic techniques.
Salaverria I; Espinet B; Carrió A; Costa D; Astier L; Slotta-Huspenina J; Quintanilla-Martinez L; Fend F; Solé F; Colomer D; Serrano S; Miró R; Beà S; Campo E
Genes Chromosomes Cancer; 2008 Dec; 47(12):1086-97. PubMed ID: 18709664
[TBL] [Abstract][Full Text] [Related]
27. Mantle cell lymphoma with a novel t(11;12)(q13;p11.2): a proposed alternative mechanism of CCND1 up-regulation.
Menke JR; Vasmatzis G; Murphy S; Yang L; Menke DM; Tun HW; King RL; Smoley SA; Ketterling RP; Sukov WR
Hum Pathol; 2017 Jun; 64():207-212. PubMed ID: 28132860
[TBL] [Abstract][Full Text] [Related]
28. MRD detection in B-cell non-Hodgkin lymphomas using Ig gene rearrangements and chromosomal translocations as targets for real-time quantitative PCR.
Pott C; Brüggemann M; Ritgen M; van der Velden VH; van Dongen JJ; Kneba M
Methods Mol Biol; 2013; 971():175-200. PubMed ID: 23296964
[TBL] [Abstract][Full Text] [Related]
29. An overlapping case of in situ mantle cell neoplasia and leukemic non-nodal mantle cell lymphoma.
Matsuoka R; Sakamoto N; Sakata-Yanagimoto M; Chiba S; Noguchi M; Nakamura N
J Clin Exp Hematop; 2020 Dec; 60(4):169-173. PubMed ID: 33028761
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA expression, chromosomal alterations, and immunoglobulin variable heavy chain hypermutations in Mantle cell lymphomas.
Navarro A; Beà S; Fernández V; Prieto M; Salaverria I; Jares P; Hartmann E; Mozos A; López-Guillermo A; Villamor N; Colomer D; Puig X; Ott G; Solé F; Serrano S; Rosenwald A; Campo E; Hernández L
Cancer Res; 2009 Sep; 69(17):7071-8. PubMed ID: 19690137
[TBL] [Abstract][Full Text] [Related]
31. Identification of miR-15b as a transformation-related factor in mantle cell lymphoma.
Arakawa F; Kimura Y; Yoshida N; Miyoshi H; Doi A; Yasuda K; Nakajima K; Kiyasu J; Niino D; Sugita Y; Tashiro K; Kuhara S; Seto M; Ohshima K
Int J Oncol; 2016 Feb; 48(2):485-92. PubMed ID: 26676972
[TBL] [Abstract][Full Text] [Related]
32. Combined molecular diagnosis of B-cell lymphomas with t(11;14)(q13;q32) or t(14;18)(q32;q21) using multiplex- and long distance inverse-polymerase chain reaction.
Vieira L; Martinho A; Antunes O; Silva E; Ambrósio AP; Geraldes MC; Nascimento R; Silva C; Pereira JM; Júnior EC; Jordan P
Diagn Mol Pathol; 2008 Jun; 17(2):73-81. PubMed ID: 18382373
[TBL] [Abstract][Full Text] [Related]
33. A Cryptic t(11;14) Translocation in Mantle Cell Lymphoma Highlights the Importance of FISH.
Kallen ME; Kim Y; Yang L; Rao NP; Tirado CA
J Assoc Genet Technol; 2015; 41(1):13-6. PubMed ID: 26029939
[TBL] [Abstract][Full Text] [Related]
34. Whole genome copy number analysis in search of new prognostic biomarkers in first line treatment of mantle cell lymphoma. A study by the LYSA group.
Le Bris Y; Magrangeas F; Moreau A; Chiron D; Guérin-Charbonnel C; Theisen O; Pichon O; Canioni D; Burroni B; Maisonneuve H; Thieblemont C; Oberic L; Gyan E; Pellat-Deceunynck C; Hermine O; Delfau-Larue MH; Tessoulin B; Béné MC; Minvielle S; Le Gouill S
Hematol Oncol; 2020 Oct; 38(4):446-455. PubMed ID: 32472610
[TBL] [Abstract][Full Text] [Related]
35. Cyclin D1 (CCND1) messenger RNA expression as assessed by real-time PCR contributes to diagnosis and follow-up control in patients with mantle cell lymphoma.
Bacher U; Kern W; Haferlach C; Alpermann T; Haferlach T; Schnittger S
Exp Hematol; 2013 Dec; 41(12):1028-37. PubMed ID: 24060591
[TBL] [Abstract][Full Text] [Related]
36. Mantle cell lymphomas.
Rodriguez MA; Pugh WC
Cancer Treat Res; 1996; 85():41-50. PubMed ID: 9043774
[TBL] [Abstract][Full Text] [Related]
37. A cyclin D1-negative mantle cell lymphoma with an IGL-CCND2 translocation that relapsed with blastoid morphology and aggressive clinical behavior.
Kurita D; Takeuchi K; Kobayashi S; Hojo A; Uchino Y; Sakagami M; Ohtake S; Takahashi H; Miura K; Iriyama N; Sugitani M; Miyoshi H; Hatta Y; Ohshima K; Takei M
Virchows Arch; 2016 Oct; 469(4):471-6. PubMed ID: 27457074
[TBL] [Abstract][Full Text] [Related]
38. Cyclin D1-positive diffuse large B-cell lymphoma with IGH-CCND1 translocation and BCL6 rearrangement: a report of two cases.
Al-Kawaaz M; Mathew S; Liu Y; Gomez ML; Chaviano F; Knowles DM; Orazi A; Tam W
Am J Clin Pathol; 2015 Feb; 143(2):288-99. PubMed ID: 25596256
[TBL] [Abstract][Full Text] [Related]
39. [Molecular diagnosis of malignant B-cell lymphoma: detection of clonality and a brief review of problems with our results].
Krsková L; Hilská I; Kopecká P; Soukup J; Kodet R
Cas Lek Cesk; 2004; 143(3):191-4. PubMed ID: 15134040
[TBL] [Abstract][Full Text] [Related]
40. Leukemic Non-nodal Mantle Cell Lymphoma: Diagnosis and Treatment.
Jain AG; Chang CC; Ahmad S; Mori S
Curr Treat Options Oncol; 2019 Nov; 20(12):85. PubMed ID: 31776787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
